Search - tctmd.com

Displaying 641 - 660 of 2417

Sort: Relevancy | Date

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

Presentation

Relationship Between Stent Type and QoL Following PCI for Acute MI

Presenter: Adnan K. Chhatriwalla

July 30, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

News Daily News

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

July 30, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

July 30, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

Presentation

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Presenter: Robert A. Henderson

July 29, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Daily News

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

Yael L. Maxwell

July 29, 2015

Advertisement

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Relationship Between Stent Type and QoL Following PCI for Acute MI

EES vs CABG for Patients With Diabetes and Multivessel Disease

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content